Indeed, O’Brien et al. [22] demonstrated that in immunodeficient mice, human colon cancer-initiating cells are CD133+ and as opposite, CD133- cells are unable to initiate tumor growth. The gene discussed is PROM1; the disease is malignant colon neoplasm.